Report: FDA Lacks Information Necessary to Monitor Risk Evaluation and Mitigation Strategies
March 15th 2013In many cases, the FDA is not getting the information it needs to oversee plans submitted by drug manufacturers to ensure that potentially risky drugs are used safely, according to a recently released government report.